Scholars Central

Conference abstractPublished 2018

Generic Innovative Products

Authors: Takafumi Atarashi

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In the past ten years, Japan has taken the form of giving benefits to medical institutions and dispensing pharmacies for dissemination of generic drugs. Among the medicines for which patent wants to break now, generic drugs have nearly 70% market share, but the country aims at something more than 80%. Meanwhile, long-term listed drugs from the year when the patent expired in 10 to 12 years, will be as the same price as generic drugs. For generic pharmaceutical companies and original drug companies that are not going to develop new drugs are also in a very difficult situation. In order to overcome competition in the long-listed items and generic drug market, it is necessary not only to price strategy, but also generic innovative product such as Tablet size changes, DDS change and package changes, have been requested. Japan is required to have value-added generics than other countries.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Primary Health Care: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPrimary Health Care: Open Access
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Takafumi Atarashi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels